Correlation Between Vyne Therapeutics and Harmony Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Harmony Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Harmony Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Harmony Biosciences Holdings, you can compare the effects of market volatilities on Vyne Therapeutics and Harmony Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Harmony Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Harmony Biosciences.

Diversification Opportunities for Vyne Therapeutics and Harmony Biosciences

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vyne and Harmony is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Harmony Biosciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harmony Biosciences and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Harmony Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harmony Biosciences has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Harmony Biosciences go up and down completely randomly.

Pair Corralation between Vyne Therapeutics and Harmony Biosciences

Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 0.78 times more return on investment than Harmony Biosciences. However, Vyne Therapeutics is 1.29 times less risky than Harmony Biosciences. It trades about 0.06 of its potential returns per unit of risk. Harmony Biosciences Holdings is currently generating about 0.01 per unit of risk. If you would invest  284.00  in Vyne Therapeutics on August 27, 2024 and sell it today you would earn a total of  11.00  from holding Vyne Therapeutics or generate 3.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vyne Therapeutics  vs.  Harmony Biosciences Holdings

 Performance 
       Timeline  
Vyne Therapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Harmony Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Harmony Biosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Harmony Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Vyne Therapeutics and Harmony Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vyne Therapeutics and Harmony Biosciences

The main advantage of trading using opposite Vyne Therapeutics and Harmony Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Harmony Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harmony Biosciences will offset losses from the drop in Harmony Biosciences' long position.
The idea behind Vyne Therapeutics and Harmony Biosciences Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories